Most cited papers from Biogen (United States)

Biogen (United States)

What are the most cited papers from Biogen (United States)?

The most cited paper from Biogen (United States) is "Genomic sequencing." (George M. Church, W Gilbert, 1984), with 8,225 citations. Next come "A metagenome-wide association study of gut microbiota in type 2 diabetes" (7,088) and "FinnGen provides genetic insights from a well-phenotyped isolated population" (4,362).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 912 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Genomic sequencing. George M. Church, W Gilbert · Proceedings of the National Academy of Sciences Open access	Apr 1984	8,225
2	A metagenome-wide association study of gut microbiota in type 2 diabetes Junjie Qin et al. · Nature Open access	25 Sep 2012	7,088
3	FinnGen provides genetic insights from a well-phenotyped isolated population Mitja Kurki et al. · Nature Open access169 authors	18 Jan 2023	4,362
4	Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN Zvi Gregorio Fridlender, Jing Sun, SAMUEL C. KIM et al. · Cancer Cell Open access	Sep 2009	3,436
5	A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis Chris H. Polman, Paul W O'Connor, Eva Havrdová et al. · New England Journal of Medicine Open access	Mar 2006	3,396
6	The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Jeff Sevigny et al. · Nature	30 Aug 2016	3,131
7	Mapping genomic loci implicates genes and synaptic biology in schizophrenia Vassily Vladimirovich Trubetskoy et al. · Nature Open access613 authors	8 Apr 2022	2,894
8	The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress Truyen Nguyen, Paul Nioi, Cecil B. Pickett · Journal of Biological Chemistry Open access	Feb 2009	2,697
9	New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics Open access1,266 authors	Apr 2022	2,608
10	Genomic atlas of the human plasma proteome Benjamin B. Sun et al. · Nature Open access	29 May 2018	2,496
11	Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis Lawrence D. Jacobs et al. · Annals of Neurology	Mar 1996	2,458
12	B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis Stephen L. Hauser, Emmanuelle L. Waubant, Douglas Lorne Arnold et al. · New England Journal of Medicine Open access	13 Feb 2008	2,441
13	Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel et al. · New England Journal of Medicine Open access	Nov 2017	2,357
14	The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements Leming M. Shi et al. · Nature Biotechnology Open access138 authors	Sep 2006	2,178
15	Immune attack: the role of inflammation in Alzheimer disease Frank L. Heppner, Richard M. Ransohoff, Burkhard Becher · Nature reviews. Neuroscience Review	20 May 2015	2,169
16	How neuroinflammation contributes to neurodegeneration Richard M. Ransohoff · Science	18 Aug 2016	2,021
17	Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury Won Kon Han, Véronique Bailly, Rekha Abichandani et al. · Kidney International Open access	Jul 2002	1,954
18	VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site Mariano J. Elices, Laurelee Osborn, Yoshikazu Takada et al. · Cell	Feb 1990	1,832
19	Control of coleopteran insect pests through RNA interference James A. Baum, Thierry Bogaert, William P. Clinton et al. · Nature Biotechnology	Nov 2007	1,816
20	Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis Ralf Gold, Ludwig Kappos, Douglas Lorne Arnold et al. · New England Journal of Medicine Open access	19 Sep 2012	1,735
21	Plasma proteomic associations with genetics and health in the UK Biobank Benjamin B. Sun et al. · Nature Open access	4 Oct 2023	1,716
22	Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes Laurelee Osborn, Catherine A. Hession, Richard Tizard et al. · Cell	22 Dec 1989	1,701
23	Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis Sha Mi, Xinhua Lee, Xiangping Li et al. · Nature	Feb 2000	1,686
24	Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks Stanley B. Cohen, Paul E. Emery, Maria Greenwald et al. · Arthritis & Rheumatism	31 Aug 2006	1,651
25	A polarizing question: do M1 and M2 microglia exist? Richard M. Ransohoff · Nature Neuroscience	26 Jul 2016	1,616
26	Architecture of the human interactome defines protein communities and disease networks Edward L. Huttlin et al. · Nature Open access	May 2017	1,587
27	The BioPlex Network: A Systematic Exploration of the Human Interactome Edward L. Huttlin et al. · Cell Open access	Jul 2015	1,567
28	Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program J Gäbert, Emmanuel Jean Beillard, Vincent H. J. van der Velden et al. · Leukemia	9 Oct 2003	1,540
29	Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis Lawrence D. Jacobs, Roy W. Beck, Jack H. Simon et al. · New England Journal of Medicine Open access	28 Sep 2000	1,514
30	A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Douglas Adam Rubinson, Christopher P. Dillon, Adam V. Kwiatkowski et al. · Nature Genetics	18 Feb 2003	1,509
31	Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations Fabienne Mackay, Stephen A. Woodcock, Pornsri Lawton et al. · The Journal of Experimental Medicine Open access	6 Dec 1999	1,483
32	Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy Eugenio Maria Mercuri et al. · New England Journal of Medicine Open access	14 Feb 2018	1,466
33	Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease Samantha Budd Haeberlein et al. · The Journal of Prevention of Alzheimer s Disease Open access	15 Mar 2022	1,377
34	An environment-dependent transcriptional network specifies human microglia identity David Gosselin, Dylan Skola, Nicole G. Coufal et al. · Science Open access	25 May 2017	1,356
35	Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine Open access	19 Sep 2012	1,356
36	Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine Open access	Mar 2006	1,347
37	BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth Pascal Schneider, Fabienne Mackay, Véronique Steiner et al. · The Journal of Experimental Medicine Open access	7 Jun 1999	1,340
38	A chemokine-driven positive feedback loop organizes lymphoid follicles Karl Mark Ansel, Vu N. Ngo, Paul L. Hyman et al. · Nature	Jul 2000	1,300
39	A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait Randall D. Little et al. · The American Journal of Human Genetics Open access	2002	1,295
40	Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury Takaharu Ichimura, Joseph Vincent Bonventre, Véronique Bailly et al. · Journal of Biological Chemistry Open access	Feb 1998	1,277
41	Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Gary Bloomgren, Sandra Richman, Christophe Hotermans et al. · New England Journal of Medicine Open access	17 May 2012	1,255
42	Tat-mediated delivery of heterologous proteins into cells. Stephen E. Fawell, J Seery, Yasmin Daikh et al. · Proceedings of the National Academy of Sciences Open access	18 Jan 1994	1,232
43	Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway Ralf Andreas Linker, De-Hyung Lee, Sarah T. Ryan et al. · Brain	22 Feb 2011	1,197
44	The UK10K project identifies rare variants in health and disease Writing group et al. · Nature Open access349 authors	14 Sep 2015	1,195
45	Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Jeffrey Ian Weitz, Monika Hudoba, David R. Massel et al. · Journal of Clinical Investigation Open access	Aug 1990	1,128
46	Finding function in novel targets: C. elegans as a model organism Titus Kaletta, Michael Otmar Hengartner · Nature Reviews Drug Discovery Review	21 Apr 2006	1,111
47	Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness Paul Van Eerdewegh et al. · Nature	Jul 2002	1,104
48	An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway Barbara J. Schiemann, Jennifer L. Gommerman, Kalpit A. Vora et al. · Science	14 Sep 2001	1,068
49	STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus Elaine F. Remmers et al. · New England Journal of Medicine Open access	5 Sep 2007	1,056
50	Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells Richard L. Cate, Robert J. Mattaliano, Catherine A. Hession et al. · Cell	Jun 1986	1,030

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.